SHANGHAI--(BUSINESS WIRE)--Sidley Austin LLP is pleased to announce that Dr. Ling Su, a non-lawyer who is a seasoned drug development professional, has joined the firm as a Strategic Advisor in its China Life Sciences practice. He will draw from his extensive regulatory and industry experience to advise clients on the non-legal aspects of the Chinese regulatory and clinical trial environment as it pertains to product development, clinical trial implementation and other related issues. Dr. Su bri
For more information, please visit
http://www.businesswire.com/news/home/20[...]P-Expands-Global-Life-Sciences